Financials EVE Health Group Limited

Equities

EVE

AU000000EVE3

Other Specialty Retailers

Delayed Australian S.E. 11:32:02 2024-04-08 pm EDT 5-day change 1st Jan Change
0.001 AUD 0.00% Intraday chart for EVE Health Group Limited 0.00% 0.00%

Valuation

Fiscal Period: Juni 2018 2019 2020 2021 2022 2023
Capitalization 1 17.91 11.97 22.36 15.37 5.05 5.274
Enterprise Value (EV) 1 14 12.93 17.8 13.23 4.44 5.086
P/E ratio -8 x -4.36 x -7.51 x -4.21 x -0.75 x -1.29 x
Yield - - - - - -
Capitalization / Revenue 947 x 7.49 x 9.67 x 5.49 x 2.11 x 2.26 x
EV / Revenue 740 x 8.09 x 7.7 x 4.72 x 1.86 x 2.18 x
EV / EBITDA - -6,552,714 x -7,086,194 x -3,703,393 x -1,042,308 x -2,359,066 x
EV / FCF -31.3 x -33.4 x -6.15 x -7.24 x -1.74 x -1.6 x
FCF Yield -3.2% -3% -16.3% -13.8% -57.6% -62.5%
Price to Book 2.43 x 2.05 x 1.72 x 1.51 x 0.73 x 1.69 x
Nbr of stocks (in thousands) 2,238,804 2,393,314 3,726,225 3,843,142 5,050,483 5,274,483
Reference price 2 0.008000 0.005000 0.006000 0.004000 0.001000 0.001000
Announcement Date 8/31/18 9/16/19 8/31/20 8/31/21 10/2/22 9/29/23
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Juni 2018 2019 2020 2021 2022 2023
Net sales 1 0.0189 1.598 2.311 2.801 2.391 2.331
EBITDA - -1.973 -2.512 -3.572 -4.26 -2.156
EBIT 1 -1.625 -2.134 -2.749 -3.808 -4.498 -2.35
Operating Margin -8,597.54% -133.52% -118.96% -135.94% -188.16% -100.84%
Earnings before Tax (EBT) 1 -1.88 -2.639 -3.004 -3.631 -5.372 -2.349
Net income 1 -1.88 -2.639 -2.4 -3.631 -5.372 -4.044
Net margin -9,944.97% -165.13% -103.86% -129.62% -224.71% -173.51%
EPS 2 -0.001000 -0.001147 -0.000799 -0.000949 -0.001339 -0.000774
Free Cash Flow 1 -0.4479 -0.3874 -2.894 -1.826 -2.557 -3.177
FCF margin -2,369.12% -24.25% -125.22% -65.2% -106.97% -136.29%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 8/31/18 9/16/19 8/31/20 8/31/21 10/2/22 9/29/23
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 - 0.96 - - - -
Net Cash position 1 3.91 - 4.55 2.15 0.61 0.19
Leverage (Debt/EBITDA) - -0.4865 x - - - -
Free Cash Flow 1 -0.45 -0.39 -2.89 -1.83 -2.56 -3.18
ROE (net income / shareholders' equity) -37% -39.9% -25.5% -31.3% -62.8% -46.7%
ROA (Net income/ Total Assets) -19.3% -16.4% -15% -18.3% -28.1% -24.1%
Assets 1 9.743 16.06 15.99 19.86 19.1 16.8
Book Value Per Share 2 0 0 0 0 0 0
Cash Flow per Share 2 0 0 0 0 0 0
Capex - 0.06 0.32 0.26 0.03 0
Capex / Sales - 3.97% 13.96% 9.4% 1.09% 0.07%
Announcement Date 8/31/18 9/16/19 8/31/20 8/31/21 10/2/22 9/29/23
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Chiffre d''affaires - Rate of surprise

  1. Stock Market
  2. Equities
  3. EVE Stock
  4. Financials EVE Health Group Limited